112 related articles for article (PubMed ID: 32437521)
1. ARSA gene variants and Parkinson's disease.
Fan Y; Mao CY; Dong YL; Shen S; Zhang QM; Yao DB; Liu F; Li MJ; Hu XC; Wang T; Liu YT; Liu H; Wang YL; Yuan YP; Zhang C; Yang J; Shi CH; Xu YM
Brain; 2020 Jun; 143(6):e47. PubMed ID: 32437521
[No Abstract] [Full Text] [Related]
2. Reply: ARSA gene variants and Parkinson's disease.
Lee SJ; Lee JS; Funayama M; Yoo HS; Lee PH; Hattori N
Brain; 2020 Jun; 143(6):e48. PubMed ID: 32437537
[No Abstract] [Full Text] [Related]
3. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the role of ARSA in Chinese patients with Parkinson's disease.
Pan HX; Wang YG; Zhao YW; Zeng Q; Wang Z; Fang ZH; Zhang Y; Zhou X; He RC; Xu Q; Sun QY; Tan JQ; Yan XX; Li JC; Tang BS; Guo JF
Neurobiol Aging; 2022 Jan; 109():269-272. PubMed ID: 34531044
[TBL] [Abstract][Full Text] [Related]
5. ARSA variants in α-synucleinopathies.
Makarious MB; Diez-Fairen M; Krohn L; Blauwendraat C; Bandres-Ciga S; Ding J; Pihlstrøm L; Houlden H; Scholz SW; Gan-Or Z
Brain; 2019 Dec; 142(12):e70. PubMed ID: 31670782
[No Abstract] [Full Text] [Related]
6. Genetic analysis of arylsulfatase A (ARSA) in Chinese patients with Parkinson's disease.
Ruan Y; Zheng R; Lin ZH; Gao T; Xue NJ; Cao J; Tian J; Zhang BR; Pu JL
Neurosci Lett; 2020 Aug; 734():135094. PubMed ID: 32470555
[TBL] [Abstract][Full Text] [Related]
7. Association of Rare Variants in ARSA with Parkinson's Disease.
Senkevich K; Beletskaia M; Dworkind A; Yu E; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Nagornov I; Tyurin A; Miliukhina I; Timofeeva A; Emelyanov A; Trempe JF; Zakharova E; Alcalay RN; Pchelina S; Gan-Or Z
Mov Disord; 2023 Oct; 38(10):1806-1812. PubMed ID: 37381728
[TBL] [Abstract][Full Text] [Related]
8. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
Huang Y; Rowe DB; Halliday GM
J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
[TBL] [Abstract][Full Text] [Related]
9. Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.
Cesani M; Lorioli L; Grossi S; Amico G; Fumagalli F; Spiga I; Filocamo M; Biffi A
Hum Mutat; 2016 Jan; 37(1):16-27. PubMed ID: 26462614
[TBL] [Abstract][Full Text] [Related]
10. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
Pavlou MAS; Pinho R; Paiva I; Outeiro TF
Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
[TBL] [Abstract][Full Text] [Related]
11. Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.
Koros C; Brockmann K; Simitsi AM; Bougea A; Liu H; Hauser AK; Schulte C; Lerche S; Pachi I; Papagiannakis N; Antonelou R; Zahou A; Wurster I; Efthymiopoulou E; Beratis I; Maniati M; Moraitou M; Michelakakis H; Paraskevas G; Papageorgiou SG; Potagas C; Papadimitriou D; Bozi M; Stamelou M; Gasser T; Stefanis L
Mov Disord; 2023 May; 38(5):907-909. PubMed ID: 37148559
[No Abstract] [Full Text] [Related]
12. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction.
Goldman SM; Umbach DM; Kamel F; Tanner CM
Eur J Neurol; 2015 Jul; 22(7):e75. PubMed ID: 26060929
[No Abstract] [Full Text] [Related]
13. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease.
Botta-Orfila T; Ezquerra M; Ríos J; Fernández-Santiago R; Cervantes S; Samaranch L; Pastor P; Martí MJ; Muñoz E; Valldeoriola F; Aguilar M; Calopa M; Hernández-Vara J; Tolosa E
Eur J Neurol; 2011 Mar; 18(3):e32. PubMed ID: 21054681
[No Abstract] [Full Text] [Related]
14. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
[TBL] [Abstract][Full Text] [Related]
15. TMEM230 in Parkinson's disease.
Ibanez L; Dube U; Budde J; Black K; Medvedeva A; Davis AA; Perlmutter JS; Benitez BA; Cruchaga C
Neurobiol Aging; 2017 Aug; 56():212.e1-212.e3. PubMed ID: 28457580
[TBL] [Abstract][Full Text] [Related]
16. Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece.
Proukakis C
Eur J Neurol; 2014 Jul; 21(7):946-7. PubMed ID: 24460978
[No Abstract] [Full Text] [Related]
17. Snaring the function of alpha-synuclein.
Bonini NM; Giasson BI
Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells.
Böhringer J; Santer R; Schumacher N; Gieseke F; Cornils K; Pechan M; Kustermann-Kuhn B; Handgretinger R; Schöls L; Harzer K; Krägeloh-Mann I; Müller I
Hum Mutat; 2017 Nov; 38(11):1511-1520. PubMed ID: 28762252
[TBL] [Abstract][Full Text] [Related]
20. Expression of alpha-synuclein mRNA in Parkinson's disease.
Papapetropoulos S; Adi N; Mash DC; Shehadeh L; Bishopric N; Shehadeh L
Mov Disord; 2007 May; 22(7):1057-9; author reply 1057. PubMed ID: 17373725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
